May 23, 2019
Constellation Pharmaceuticals to Host Analyst/Investor Meeting at ASCO to Discuss Interim Update of Data of CPI-0610 in MANIFEST Clinical Trial.
May 22, 2019
Celsius Therapeutics Announces Executive Leadership Team Appointments.
May 21, 2019
Sesen Bio Announces Acceptance of Analytical Comparability Plan by the U.S. Food and Drug Administration to Support the BLA and Commercialization of Its Lead Asset, Vicinium® for Non-Muscle Invasive Bladder Cancer.
May 20, 2019
Voyager Therapeutics Announces Management Updates.
May 17, 2019
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(C)(4).